Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1998 Aug;35(8):617–623. doi: 10.1136/jmg.35.8.617

Hirschsprung disease, microcephaly, mental retardation, and characteristic facial features: delineation of a new syndrome and identification of a locus at chromosome 2q22-q23.

D R Mowat 1, G D Croaker 1, D T Cass 1, B A Kerr 1, J Chaitow 1, L C Adès 1, N L Chia 1, M J Wilson 1
PMCID: PMC1051383  PMID: 9719364

Abstract

We have identified six children with a distinctive facial phenotype in association with mental retardation (MR), microcephaly, and short stature, four of whom presented with Hirschsprung (HSCR) disease in the neonatal period. HSCR was diagnosed in a further child at the age of 3 years after investigation for severe chronic constipation and another child, identified as sharing the same facial phenotype, had chronic constipation, but did not have HSCR. One of our patients has an interstitial deletion of chromosome 2, del(2)(q21q23). These children strongly resemble the patient reported by Lurie et al with HSCR and dysmorphic features associated with del(2)(q22q23). All patients have been isolated cases, suggesting a contiguous gene syndrome or a dominant single gene disorder involving a locus for HSCR located at 2q22-q23. Review of published reports suggests that there is significant phenotypic and genetic heterogeneity within the group of patients with HSCR, MR, and microcephaly. In particular, our patients appear to have a separate disorder from Goldberg-Shprintzen syndrome, for which autosomal recessive inheritance has been proposed because of sib recurrence and consanguinity in some families.

Full text

PDF
617

Images in this article

618Image
on p.618
619Image
on p.619
620Image
on p.620

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angrist M., Bolk S., Halushka M., Lapchak P. A., Chakravarti A. Germline mutations in glial cell line-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient. Nat Genet. 1996 Nov;14(3):341–344. doi: 10.1038/ng1196-341. [DOI] [PubMed] [Google Scholar]
  2. Attié T., Pelet A., Edery P., Eng C., Mulligan L. M., Amiel J., Boutrand L., Beldjord C., Nihoul-Fékété C., Munnich A. Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease. Hum Mol Genet. 1995 Aug;4(8):1381–1386. doi: 10.1093/hmg/4.8.1381. [DOI] [PubMed] [Google Scholar]
  3. Attié T., Till M., Pelet A., Amiel J., Edery P., Boutrand L., Munnich A., Lyonnet S. Mutation of the endothelin-receptor B gene in Waardenburg-Hirschsprung disease. Hum Mol Genet. 1995 Dec;4(12):2407–2409. doi: 10.1093/hmg/4.12.2407. [DOI] [PubMed] [Google Scholar]
  4. Attié T., Till M., Pelet A., Amiel J., Edery P., Boutrand L., Munnich A., Lyonnet S. Mutation of the endothelin-receptor B gene in Waardenburg-Hirschsprung disease. Hum Mol Genet. 1995 Dec;4(12):2407–2409. doi: 10.1093/hmg/4.12.2407. [DOI] [PubMed] [Google Scholar]
  5. Brunoni D., Joffe R., Farah L. M., Cunha A. J. Syndrome identification case report 92: Hirschsprung megacolon, cleft lip and palate, mental retardation, and minor congenital malformations. J Clin Dysmorphol. 1983 Spring;1(1):20–22. [PubMed] [Google Scholar]
  6. Dib C., Fauré S., Fizames C., Samson D., Drouot N., Vignal A., Millasseau P., Marc S., Hazan J., Seboun E. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature. 1996 Mar 14;380(6570):152–154. doi: 10.1038/380152a0. [DOI] [PubMed] [Google Scholar]
  7. Edery P., Attié T., Amiel J., Pelet A., Eng C., Hofstra R. M., Martelli H., Bidaud C., Munnich A., Lyonnet S. Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome). Nat Genet. 1996 Apr;12(4):442–444. doi: 10.1038/ng0496-442. [DOI] [PubMed] [Google Scholar]
  8. Edery P., Lyonnet S., Mulligan L. M., Pelet A., Dow E., Abel L., Holder S., Nihoul-Fékété C., Ponder B. A., Munnich A. Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature. 1994 Jan 27;367(6461):378–380. doi: 10.1038/367378a0. [DOI] [PubMed] [Google Scholar]
  9. Edery P., Lyonnet S., Mulligan L. M., Pelet A., Dow E., Abel L., Holder S., Nihoul-Fékété C., Ponder B. A., Munnich A. Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature. 1994 Jan 27;367(6461):378–380. doi: 10.1038/367378a0. [DOI] [PubMed] [Google Scholar]
  10. Fryns J. P., Van Bosstraeten B., Malbrain H., Van den Berghe H. Interstitial deletion of the long arm of chromosome 2 in a polymalformed newborn--karyotype: 46,XX,del(2)(q21;q24). Hum Genet. 1977 Nov 10;39(2):233–238. doi: 10.1007/BF00287018. [DOI] [PubMed] [Google Scholar]
  11. Goldberg R. B., Shprintzen R. J. Hirschsprung megacolon and cleft palate in two sibs. J Craniofac Genet Dev Biol. 1981;1(2):185–189. [PubMed] [Google Scholar]
  12. Halal F., Morel J. The syndrome of Hirschsprung disease, microcephaly, unusual face, and mental retardation. Am J Med Genet. 1990 Sep;37(1):106–108. doi: 10.1002/ajmg.1320370125. [DOI] [PubMed] [Google Scholar]
  13. Hofstra R. M., Osinga J., Tan-Sindhunata G., Wu Y., Kamsteeg E. J., Stulp R. P., van Ravenswaaij-Arts C., Majoor-Krakauer D., Angrist M., Chakravarti A. A homozygous mutation in the endothelin-3 gene associated with a combined Waardenburg type 2 and Hirschsprung phenotype (Shah-Waardenburg syndrome). Nat Genet. 1996 Apr;12(4):445–447. doi: 10.1038/ng0496-445. [DOI] [PubMed] [Google Scholar]
  14. Hurst J. A., Markiewicz M., Kumar D., Brett E. M. Unknown syndrome: Hirschsprung's disease, microcephaly, and iris coloboma: a new syndrome of defective neuronal migration. J Med Genet. 1988 Jul;25(7):494–497. doi: 10.1136/jmg.25.7.494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kumasaka K., Clarren S. K. Familial patterns of central nervous system dysfunction, growth deficiency, facial clefts and congenital megacolon: a specific disorder? Am J Med Genet. 1988 Oct;31(2):465–466. doi: 10.1002/ajmg.1320310227. [DOI] [PubMed] [Google Scholar]
  16. Lurie I. W., Supovitz K. R., Rosenblum-Vos L. S., Wulfsberg E. A. Phenotypic variability of del(2) (q22-q23): report of a case with a review of the literature. Genet Couns. 1994;5(1):11–14. [PubMed] [Google Scholar]
  17. McConnell T. S., Kornfeld M., McClellan G., Aase J. Partial deletion of chromosome 2 mimicking a phenotype of trisomy 18: case report with autopsy. Hum Pathol. 1980 Mar;11(2):202–205. doi: 10.1016/s0046-8177(80)80146-8. [DOI] [PubMed] [Google Scholar]
  18. Palmer C. G., Heerema N., Bull M. Deletions in chromosome 2 and fragile sites. Am J Med Genet. 1990 Jun;36(2):214–218. doi: 10.1002/ajmg.1320360215. [DOI] [PubMed] [Google Scholar]
  19. Puffenberger E. G., Hosoda K., Washington S. S., Nakao K., deWit D., Yanagisawa M., Chakravart A. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell. 1994 Dec 30;79(7):1257–1266. doi: 10.1016/0092-8674(94)90016-7. [DOI] [PubMed] [Google Scholar]
  20. Puffenberger E. G., Hosoda K., Washington S. S., Nakao K., deWit D., Yanagisawa M., Chakravart A. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell. 1994 Dec 30;79(7):1257–1266. doi: 10.1016/0092-8674(94)90016-7. [DOI] [PubMed] [Google Scholar]
  21. Romeo G., Ronchetto P., Luo Y., Barone V., Seri M., Ceccherini I., Pasini B., Bocciardi R., Lerone M., Käriäinen H. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature. 1994 Jan 27;367(6461):377–378. doi: 10.1038/367377a0. [DOI] [PubMed] [Google Scholar]
  22. Romeo G., Ronchetto P., Luo Y., Barone V., Seri M., Ceccherini I., Pasini B., Bocciardi R., Lerone M., Käriäinen H. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature. 1994 Jan 27;367(6461):377–378. doi: 10.1038/367377a0. [DOI] [PubMed] [Google Scholar]
  23. Salomon R., Attié T., Pelet A., Bidaud C., Eng C., Amiel J., Sarnacki S., Goulet O., Ricour C., Nihoul-Fékété C. Germline mutations of the RET ligand GDNF are not sufficient to cause Hirschsprung disease. Nat Genet. 1996 Nov;14(3):345–347. doi: 10.1038/ng1196-345. [DOI] [PubMed] [Google Scholar]
  24. Shabtai F., Klar D., Halbrecht I. Partial monosomy of chromosome 2. Delineable syndrome of deletion 2 (q23-q31). Ann Genet. 1982;25(3):156–158. [PubMed] [Google Scholar]
  25. Takahashi Y., Narahara K., Kikkawa K., Wakita Y., Kimura S., Murakami M., Kasai R., Kimoto H. Interstitial deletion of the long arm of chromosome 2: a case report and review of the literature. Jinrui Idengaku Zasshi. 1985 Dec;30(4):297–305. doi: 10.1007/BF01907967. [DOI] [PubMed] [Google Scholar]
  26. Tanaka H., Ito J., Cho K., Mikawa M. Hirschsprung disease, unusual face, mental retardation, epilepsy, and congenital heart disease: Goldberg-Shprintzen syndrome. Pediatr Neurol. 1993 Nov-Dec;9(6):479–481. doi: 10.1016/0887-8994(93)90029-c. [DOI] [PubMed] [Google Scholar]
  27. Valera-Huezo S., Fragoso R., Rivera H., Moller M., Cantú J. M. del (2) (q2300q24.1) de novo. Bol Med Hosp Infant Mex. 1986 Jun;43(6):375–377. [PubMed] [Google Scholar]
  28. Yomo A., Taira T., Kondo I. Goldberg-Shprintzen syndrome: Hirschsprung disease, hypotonia, and ptosis in sibs. Am J Med Genet. 1991 Nov 1;41(2):188–191. doi: 10.1002/ajmg.1320410211. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES